The Impact of High-risk Drugs and Deprescribing Guidelines

Deprescribing is a judicial review and withdrawal of medications no longer needed in elderly patients. In my DNP capstone project I have been studying deprescribing for the past 18 months. Elderly patients in the United States account for one-third of all prescriptions (Mangin et al., 2018). The Center for Disease Control and Prevention (CDC), in a 2003 Morbidity and Mortality Weekly Report (MMWR), projected that by 2030 the United States would have over 71 million people age 65 and older compared to 35 million in 2000. With longevity comes more comorbid conditions, which potentially results in an increased number of prescribed drugs a patient receives. With a worldwide aging population, a significant focus on patient safety, including medication errors and death, providers around the world are going to need to work together to tackle this critical issue. Please join me for this very important topic.

Disclosures:

1. Criteria for successful completion: Watch the recording in its entirety and mark lessons as complete. A certificate will be provided and available for download after the final part of the online course is marked as complete.

2. There are no relevant financial relationships with ineligible companies for those with the ability to control the content of this activity.

3. Montana Nurses Association is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

4. This activity is available for contact hours through 12/31/2023.

Contact hours awarded upon successful completion: 1, including 1 Rx contact hour

Questions? Email them to [email protected]

Choose a Pricing Option

$40

The Impact of High-risk Drugs and Deprescribing Guidelines

Session 18 of 2022's APRN Conference

Deprescribing is a judicial review and withdrawal of medications no longer needed in elderly patients. In my DNP capstone project I have been studying deprescribing for the past 18 months. Elderly patients in the United States account for one-third of all prescriptions (Mangin et al., 2018). The Center for Disease Control and Prevention (CDC), in a 2003 Morbidity and Mortality Weekly Report (MMWR), projected that by 2030 the United States would have over 71 million people age 65 and older compared to 35 million in 2000. With longevity comes more comorbid conditions, which potentially results in an increased number of prescribed drugs a patient receives. With a worldwide aging population, a significant focus on patient safety, including medication errors and death, providers around the world are going to need to work together to tackle this critical issue. Please join me for this very important topic.

Rebecca Muller began her nursing career in 1983. She has worked a multitude of positions and practices over the years. Rebecca currently works at MT VA as an FNP in HBPC, Faculty for MSU Billings RN-BSN program, and the Medical Director for Student Health Services at MSU Billings. Her DNP Capstone Project has been on Deprescribing High-Risk Medications in Elderly Patients.